Major pharmaceutical company Biogen is investing $1billion to take LRRK2 inhibitors into large scale clinical trials in 2021.
We’re investing a further £1 million to drive forward drugs that target energy-producing mitochondria to slow the loss of brain cells in Parkinson's.
Researchers are taking steps to invite people back to take part in face-to-face studies. To help them make sure their research resumes in a safe, practical, and convenient way, we'd like you to take part in a survey.
Government missed target on recruiting mental health staff. This could impact on people with Parkinson’s
A new report released today (24 July) shows that people with neurological conditions, such as Parkinson’s, struggle to access effective mental health care that meets their needs.
An update on meetings we’ve had this week about social care that raise the concerns of our community.
With Lancaster University, we conducted a survey that shows the coronavirus restrictions are having a big impact on the lives and the health of people affected by Parkinson’s.
Medical research charities have come together and are asking the government to act now and set up a fund to ensure that the future of charity-funded research is protected
How loneliness is affecting people during the pandemic and some ways to tackle it
New one-step process converts cells inside the brain into dopamine-producing cells to replace those lost in Parkinson's.